A review of the endometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women
review
OA: closed
CC0
⤵ 12 in-corpus citations
AI-generated summary
This review examines the histological changes in the endometrium induced by progestins and progesterone receptor modulators in reproductive-aged women.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
This review compares the histologic changes that occur in the endometrium following ovulation and progesterone secretion with contraceptive progestins and progesterone receptor modulators (PRMs) that may be used as contraceptive agents in women. The morphologic endometrial changes vary by the progestin type, dosage and duration; are often subtle and difficult to interpret; and may also vary depending on whether or not estrogen is used. The prolonged use of ethinyl estradiol and a progestin as a combined oral contraceptive results in common endometrial histologic findings that include glandular and stromal atrophy and spiral arteriole underdevelopment. Intrauterine systems releasing levonorgestrel have similar changes that are related to the proximity of the device to the endometrium, while progestin-only implants result in atrophy with marked vascular changes characterized by underdevelopment of spiral arterioles and dilated, thin-walled vessels near the surface epithelium. Lower doses of levonorgestrel delivered by a vaginal ring allow ovulation, and the endometrial changes appear to reflect the impact of the endogenous hormones. PRMs have been investigated as potential female contraceptives. PRM-associated endometrial changes include an inactive endometrium with cystically dilated glands, lined by epithelium with increased apoptosis in a background of compact nondecidualized stroma. Histologic differences between PRMs appear to depend on the degree of progesterone receptor agonistic activity.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (61)
- Clinical utility of progesterone receptor modulators and their effect on the endometrium via openalex
- Intrauterine release of progesterone antagonist ZK230211 is feasible and results in novel endometrial effects: a pilot study via openalex
- MORPHOLOGY OF HAEMOSTASIS IN MENSTRUAL ENDOMETRIUM via openalex
- Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rate via openalex
- Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications via openalex
- Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety via openalex
- The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology via openalex
- W1994248779 via openalex
- W2002239473 via openalex
- W2005680123 via openalex
- W2007443170 via openalex
- W2017630958 via openalex
- W2022476740 via openalex
- W2026392453 via openalex
- W2026781892 via openalex
- doi:10.1007/s11154-012-9227-3 via openalex
- W2028832938 via openalex
- W2030652710 via openalex
- W2034864360 via openalex
- W2042617363 via openalex
- W2044060855 via openalex
- W2047203443 via openalex
- W2052168623 via openalex
- W2064757644 via openalex
- W2069624667 via openalex
- W2070900245 via openalex
- W2088306602 via openalex
- W2095860426 via openalex
- W2102218899 via openalex
- W2106587450 via openalex
- W2108010472 via openalex
- W2122146138 via openalex
- W2125652739 via openalex
- W2130196753 via openalex
- W2135843851 via openalex
- W2138228193 via openalex
- W2139527049 via openalex
- W2150002541 via openalex
- W2151996036 via openalex
- W2156957181 via openalex
- W2161584275 via openalex
- W2162602946 via openalex
- W2163946488 via openalex
- W2167566619 via openalex
- W2169954749 via openalex
- W2204640292 via openalex
- W2322885239 via openalex
- W2328597570 via openalex
- W2432274904 via openalex
- W2471254465 via openalex
- W2502502188 via openalex
- W3144701148 via openalex
- W3188571791 via openalex
- W1480609994 via openalex
- W6680500635 via openalex
- W1519147104 via openalex
- W1525668142 via openalex
- W1662400265 via openalex
- W1969068003 via openalex
- W1969611640 via openalex
- W1986178398 via openalex
Cited by (11)
- Therapeutic selection for abnormal uterine bleeding with ovulatory dysfunction: a cross-sectional study in Chinese women 2025
- Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimens 2022
- Effects of Levonorgestrel-Releasing Intrauterine Device Therapy on Ovarian Reserve in Menorrhagia 2022
- The issues of endometriosis hormonal treatment in reproductive age women 2022
- Potential Therapeutic Options and Perspectives for Alleviation of Endometrial Estrogen Dominance and Progesterone Resistance in Endometriosis 2021
- The Plasminogen Activator System, Glucocorticoid, and Mineralocorticoid Receptors in the Primate Endometrium During Artificial Menstrual Cycles 2021
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure 2020
- Postoperative desogestrel for pelvic endometriosis-related pain: a randomized controlled trial 2017
- Heavy menstrual bleeding diagnosis and medical management 2017
- The current status of hormonal therapies for heavy menstrual bleeding 2017
- Spontaneous Reproductive Tract Lesions in Aged Captive Chimpanzees 2016
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK